Schroder Investment Management Group’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-23,232
Closed -$206K – 1363
2020
Q1
$206K Buy
23,232
+805
+4% +$6.78K ﹤0.01% 1103
2019
Q4
$219K Buy
22,427
+1,730
+8% +$16.2K ﹤0.01% 1152
2019
Q3
$196K Sell
20,697
-23,865
-54% -$252K ﹤0.01% 1152
2019
Q2
$530K Buy
44,562
+9,258
+26% +$112K ﹤0.01% 1069
2019
Q1
$622K Buy
35,304
+3,161
+10% +$52.6K ﹤0.01% 978
2018
Q4
$558K Sell
32,143
-3,693
-10% -$63K ﹤0.01% 983
2018
Q3
$534K Sell
35,836
-10,063
-22% -$156K ﹤0.01% 1018
2018
Q2
$732K Sell
45,899
-7,277
-14% -$109K ﹤0.01% 996
2018
Q1
$755K Buy
53,176
+4,229
+9% +$62.6K ﹤0.01% 999
2017
Q4
$685K Buy
48,947
+10,838
+28% +$159K ﹤0.01% 1046
2017
Q3
$541K Sell
38,109
-405,237
-91% -$5.79M ﹤0.01% 1059
2017
Q2
$7.05M Sell
443,346
-50,173
-10% -$723K 0.01% 674
2017
Q1
$6.74M Buy
493,519
+19,045
+4% +$266K 0.01% 669
2016
Q4
$8.4M Sell
474,474
-204,134
-30% -$3.59M 0.02% 647
2016
Q3
$13.1M Sell
678,608
-517,278
-43% -$10.1M 0.02% 566
2016
Q2
$23.3M Sell
1,195,886
-986,334
-45% -$19.3M 0.05% 426
2016
Q1
$46M Sell
2,182,220
-192,538
-8% -$3.79M 0.1% 265
2015
Q4
$48.7M Buy
2,374,758
+657,678
+38% +$12.6M 0.1% 254
2015
Q3
$29.4M Buy
1,717,080
+94,000
+6% +$1.72M 0.06% 359
2015
Q2
$29.9M Sell
1,623,080
-12,600
-0.8% -$234K 0.06% 385
2015
Q1
$31.3M Buy
1,635,680
+930,634
+132% +$17.2M 0.06% 369
2014
Q4
$11.6M Sell
705,046
-2,600
-0.4% -$44.6K 0.02% 607
2014
Q3
$12.5M Sell
707,646
-57,908
-8% -$1.14M 0.02% 616
2014
Q2
$15.8M Buy
765,554
+236,400
+45% +$4.86M 0.02% 544
2014
Q1
$11.5M Buy
529,154
+22,654
+4% +$519K 0.01% 597
2013
Q4
$13.4M Sell
506,500
-188,200
-27% -$4.63M 0.02% 573
2013
Q3
$16.4M Buy
694,700
+482,000
+227% +$11.3M 0.04% 491
2013
Q2
$4.57M Buy
+212,700
New +$4.59M 0.01% 772

Other funds holding VIVO

Schroder Investment Management Group's VIVO Position: Q2 2020 in Review

Schroder Investment Management Group sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 23,232 shares — an estimated $206K sold.

Schroder Investment Management Group first reported a position in VIVO in Q2 2013 and held it in 28 quarters. The position peaked at $48.7M in Q4 2015. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

  • Schroder Investment Management Group reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
  • Schroder Investment Management Group sold 23,232 Meridian Bioscience Inc shares in Q2 2020, an estimated $206K.
  • Schroder Investment Management Group first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 28 quarters.
  • Schroder Investment Management Group's Meridian Bioscience Inc position peaked at $48.7M in Q4 2015.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on Schroder Investment Management Group's 13F filing for Q2 2020, filed 13 Aug 2020.